Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
INFLIXIMAB (REMICADE) INJECTION (OTHER 700207) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 27, 2026 , from http://ppman.hank.ai/transparency/procedure/700207/by-state?code_type=OTHER
“INFLIXIMAB (REMICADE) INJECTION (OTHER 700207) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/700207/by-state?code_type=OTHER. Accessed
June 27, 2026 .
“INFLIXIMAB (REMICADE) INJECTION (OTHER 700207) by State,” HANK Price Transparency ,
accessed June 27, 2026 ,
http://ppman.hank.ai/transparency/procedure/700207/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
700207 — Infliximab (remicade) Injection
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$1,490
National median
$1,490 – $1,714
IQR (p25 – p75)
2
hospitals filing
2
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 700207 (OTHER), with interquartile range
State Median p25 p75
KY $1,602 $1,490 $1,714
TX $5 $5 $5